Johnson & Johnson

Type: Company
Name: Johnson & Johnson
Nationality: United States
Fact Sheet: Fact Sheet for Johnson & Johnson
First reported 5 hours ago - Updated 1 hour ago - 3 reports

J&J to Open J-Labs Incubator at Houston’s TMC to Boost Biotechs

Young Houston biotech companies will, by late next year, have a new partner in Johnson & Johnson. The pharmaceutical giant said today that that it will house one of its J-Labs, formerly known as Janssen Labs, at the Texas Medical Center in Housto...Related ... [Published BioPortfolio - 1 hour ago]
First reported 11 hours ago - Updated 5 hours ago - 5 reports

Johnson and Johnson Joins Hands With GSK To Fight Ebola

J&J and GSK are willing to partner to develop a more effective Ebola treatment; other pharmaceutical companies are also stepping up to contribute to Ebola effortsPage 1 of 3Click Ticker to See live coverageJohnson & Johnson ( JNJ ) and GlaxoSmithKline ... [Published Bidness Etc - 7 hours ago]
First reported 7 hours ago - Updated 7 hours ago - 2 reports

Global Oral Hygiene Market 2014-2018: Key Vendors are Colgate-Palmolive, GlaxoSmithKline, Johnson & Johnson and Procter & Gamble

DUBLIN , Oct. 23, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Oral Hygiene Market 2014-2018" report to their offering.There are many problems such as dental caries and tooth decay that affect the health of teeth. ... [Published WGNT - 7 hours ago]
First reported Oct 22 2014 - Updated 11 hours ago - 36 reports

J&J Commits US$200M to Speed Ebola Vaccine Dev't

Johnson & Johnson has made a commitment of up to US$200 million to accelerate and significantly expand the production of an Ebola vaccine programme in development at its Janssen Pharmaceutical Companies. The company is collaborating with the World Health ... [Published PharmaAsia - 13 hours ago]
First reported 14 hours ago - Updated 12 hours ago - 2 reports

Boston Scientific Completes Turnaround as Mahoney Pledges Growth

Oct. 22 (Bloomberg) -- Boston Scientific Corp., the second- biggest maker of heart-rhythm devices, is on pace to increase annual sales for the first time since 2009, marking the end of a downturn that saw net losses in seven of the past eight years.While ... [Published Washington Post - 12 hours ago]
First reported 21 hours ago - Updated 13 hours ago - 2 reports

US stocks drop as winning streak ends

New York - US stocks dropped on Wednesday following mixed earnings as the market retreated after three straight sessions of big gains.At the closing bell, the Dow Jones Industrial Average stood at 16 465.11, down 149.70 points (0.90%).The broad-based ... [Published News24 - 13 hours ago]
First reported Oct 22 2014 - Updated 23 hours ago - 3 reports

Sierra Leone: Two die in violence over Ebola tests

Two people have died after violence erupted over Ebola tests in Sierra Leone. A riot occurred in Koidu Town after a medical team attempted to take a blood sample from an elderly woman suspected to be infected with the virus. The country is one of three ... [Published Yahoo! Maktoob News - Oct 22 2014]
First reported Oct 21 2014 - Updated Oct 22 2014 - 4 reports

Jury deliberations begin in first trial over DePuy's Pinnacle hips

by A jury begins deliberations in the 1st trial over DePuy Orthopaedics' Pinnacle metal-on-metal hip implant.(Reuters) - A lawyer for a Montana woman on Tuesday urged jurors in a U.S. court to find Johnson & Johnson 's (NYSE: JNJ ) DePuy Orthopaedics ... [Published MassDevice - Oct 22 2014]
First reported Oct 21 2014 - Updated Oct 22 2014 - 28 reports

Drugmakers to join forces to make millions of Ebola vaccine doses

* GlaxoSmithKline (Other OTC: GLAXF - news) sees first vaccine doses ready this year * J&J and GSK executives discuss Ebola vaccine collaboration * J&J investing up to $200 mln to accelerate programme * Bavarian Nordic (Other OTC: BVNKF - news) to receive ... [Published Yahoo! Finance UK and Ireland - Oct 22 2014]
First reported Oct 22 2014 - Updated Oct 22 2014 - 27 reports

J&J to spend up to $200M on Ebola vaccine program

Negri Sembilan Umno has slammed a Gerakan delegate for saying the Malays were “pendatang” or immigrants to this country. Its liaison chairman, Datuk Seri Mohamad Hasan (pic), said the party recorded its dismay over the remark at the Negri Sembilan Umno ... [Published Yahoo! Malaysia - Oct 22 2014]
First reported Oct 21 2014 - Updated Oct 22 2014 - 2 reports

UPDATED: Janssen recalls 13,500 bottles of Xarelto because of contamination

Johnson & Johnson's ($JNJ) Janssen unit is recalling 13,500 bottles of its top-selling anticoagulant Xarelto because of microbial contamination discovered in a sample.According to a recall notice in the latest FDA Enforcement Report, the drugmaker said ... [Published FiercePharmaManufacturing - Oct 22 2014]
First reported Oct 21 2014 - Updated Oct 21 2014 - 2 reports

Tens of thousands expected to get Ebola vaccines from January - WHO

* Clinical trials now under way to yield data on dosage * Health workers should get GSK, NewLink vaccines in Jan * Johnson & Johnson (NYSE: JNJ - news) , Russia also have candidate vaccines GENEVA, Oct 21 (Reuters) - Tens of thousands of people in West ... [Published Yahoo! Finance UK and Ireland - Oct 21 2014]

Quotes

"People who have a heart attack are at higher risk of having further events. This can have a negative impact on the quality of life of the person and their family because of worries over their future health. Any additional treatments to reduce that risk are therefore to be welcomed" Carole Longson, the NICENICE Health Technology Evaluation Centre Director, said in a statement
...for an incubator to enable the talented scientists in the region to take their innovation to the next level," Richter said in a statement. "The continued demand for our J-Labs model fueled our decision to expand with J-Labs @TMC, which furthers our goal of helping entrepreneurs advance science with the potential to become transformational solutions for patients."
...in the strong Texas life science industry," said Robert C Robbins, M D , president and chief executive officer of the Texas Medical Center. "We look forward to launching the life science incubator in our space with J-Labs and supporting their efforts to help bring innovation in the region to market."

More Content

All (3303) | News (2650) | Reports (1) | Blogs (562) | Audio/Video (5) | Fact Sheets (37) | Press Releases (43)
sort by: Date | Relevance
U.K. watchdogs back Bayer's Xarelto for heart a... [Published FiercePharma - 1 hour ago]
Johnson & Johnson to Speed Ebola Vaccine Develo... [Published Technology Networks - 1 hour ago]
Supreme Court Declines to Address CAFA Removal ... [Published JD Supra - 1 hour ago]
J&J to Open J-Labs Incubator at Houston’s TMC t... [Published BioPortfolio - 1 hour ago]
Health buyers assume ‘green’ purchasing is more... [Published Supply Management - 1 hour ago]
Hoisted from the Archives from Four Years Ago: ... [Published Brad DeLong - 2 hours ago]
Hoisted from the Archives from Four Years Ago: ... [Published J. Bradford DeLong's Grasping Reality with All ... - 2 hours ago]
J&J prepares to face ruling in first Pinnacle h... [Published FierceMedicalDevices - 2 hours ago]
Experts warn Ebola to infect 10k people per week [Published Manila Standard Today - 2 hours ago]
JAMES MONTIER: Maximizing Shareholder Value Is ... [Published Business Insider - 2 hours ago]
Europe’s Edmond de Rothschild Takes a Fresh Vie... [Published WSJ.com: Private Equity Beat - 2 hours ago]
Amber Vinson is Ebola Free, Big Pharma Teams-up... [Published The Utah People's Post - 2 hours ago]
P&G marketing leader is latest executive to jum... [Published Cincinnati Business Journal - 2 hours ago]
Ebola vaccine development will be the game changer [Published Gulf News - 3 hours ago]
Cordis launches stent graft system [Published Performance Materials Net - 3 hours ago]
Fixing "Ebolanomics" in pursuit of vaccines and... [Published Mail Online UK - 4 hours ago]
J&J heads to Texas with its R&D farm system, sc... [Published FierceBiotech - 4 hours ago]
Montana State University’s TechLink plays key r... [Published Health Canal - 4 hours ago]
J&J to Open J-Labs Incubator at Houston’s TMC t... [Published Xconomy - 5 hours ago]
Veterans on Wall Street™ Announces Keynote Spea... [Published Industrial Info Financials - 5 hours ago]
VC-backed ProNai adds five to senior management... [Published PE Hub Blog - 5 hours ago]
Could Organovo Holdings Inc. Be Running Out of ... [Published Motley Fool Discussion Boards - 5 hours ago]
Johnson & Johnson Innovation Announces New J-La... [Published FierceBiotech - 6 hours ago]
Daimler (Bauman) As a Removal Tool in Multi-Pla... [Published Drug and Device Law - 6 hours ago]
Johnson and Johnson (JNJ) Showing Resistance Ne... [Published MarketIntelligenceCenter.com - 6 hours ago]
Axxess Pharma Retains Natural Products Consulti... [Published Marketwire - Breaking News Releases - 6 hours ago]
Regulus Therapeutics: Gilead’s New Competitor? [Published Bidness Etc - 6 hours ago]
UPDATE 2-Drugmakers may need indemnity for fast... [Published London South East - 7 hours ago]
Global Oral Hygiene Market 2014-2018: Key Vendo... [Published WGNT - 7 hours ago]
Johnson and Johnson Joins Hands With GSK To Fig... [Published Bidness Etc - 7 hours ago]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Hoisted from the Archives from Four Years Ago: ... [Published Brad DeLong - 2 hours ago]
Hoisted from the Archives from Four Years Ago: What is Happening with Bond Prices? (Brad DeLong's Grasping Reality...) : It is very hard to have a bubble in bonds because there is a date certain at which the principal is repaid. In year nine you cannot ...
Hoisted from the Archives from Four Years Ago: ... [Published J. Bradford DeLong's Grasping Reality with All ... - 2 hours ago]
Hoisted from the Archives from Four Years Ago: What is Happening with Bond Prices? (Brad DeLong's Grasping Reality...) : It is very hard to have a bubble in bonds because there is a date certain at which the principal is repaid. In year nine you cannot ...
Europe’s Edmond de Rothschild Takes a Fresh Vie... [Published WSJ.com: Private Equity Beat - 2 hours ago]
One of Europe’s oldest financial institutions, Edmond de Rothschild Group, is making waves in China’s private equity market. The banking arm’s Chinese private equity unit is raising a new euro-denominated second fund to invest in health care, consumer ...
VC-backed ProNai adds five to senior management... [Published PE Hub Blog - 5 hours ago]
ProNAi Therapeutics , a developer of nucleic acid therapeutics, has expanded its senior management team with five additions. Joining the firm are Dr. Angie You as chief business and strategy officer and head of commercial; Wendy Chapman as senior vice ...
Daimler (Bauman) As a Removal Tool in Multi-Pla... [Published Drug and Device Law - 6 hours ago]
Here’s another guest post, by Richard Dean  and Peter Reed of Tucker Ellis .  They describe a successful combination (what we might call a “one-two punch” if that phrase were not already taken) of lack of personal jurisdiction under Bauman (also ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
A Major Airbag Recall Is Expanded [Published Wall Street Journal What's News - Oct 22 2014]
J&J and GSK step up Ebola vaccine race [Published Reuters Video: Business - Oct 22 2014]
A possible new Ebola vaccine from Johnson&Johnson [Published MarketWatch Morning Stock Talk - Oct 22 2014]
Earnings Reports Roll In [Published Wall Street Journal What's News - Oct 14 2014]
The Market Ends the Session Lower [Published Wall Street Journal What's News - Sep 04 2014]
1

Press Releases

sort by: Date | Relevance
Critical Alerts For Digital River, Cheniere Ene... [Published Financial Services - Oct 13 2014]
Bank of America, Google, Intel, Johnson & Johns... [Published Financial Services - Oct 13 2014]
Legal Settlement, Data Presentation, Welfare In... [Published Financial Services - Oct 01 2014]
The Zacks Analyst Blog Highlights: Gilead Scien... [Published Financial Services - Sep 29 2014]
Pharma Stocks Review - AbbVie, Merck, Johnson a... [Published Financial Services - Sep 25 2014]
1 2 3 4 5 6 7 8 9
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.